Literature DB >> 21233399

Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.

Aurélien A Sérandour1, Stéphane Avner, Frédéric Percevault, Florence Demay, Maud Bizot, Céline Lucchetti-Miganeh, Frédérique Barloy-Hubler, Myles Brown, Mathieu Lupien, Raphaël Métivier, Gilles Salbert, Jérôme Eeckhoute.   

Abstract

Transcription factors (TFs) bind specifically to discrete regions of mammalian genomes called cis-regulatory elements. Among those are enhancers, which play key roles in regulation of gene expression during development and differentiation. Despite the recognized central regulatory role exerted by chromatin in control of TF functions, much remains to be learned regarding the chromatin structure of enhancers and how it is established. Here, we have analyzed on a genomic-scale enhancers that recruit FOXA1, a pioneer transcription factor that triggers transcriptional competency of these cis-regulatory sites. Importantly, we found that FOXA1 binds to genomic regions showing local DNA hypomethylation and that its cell-type-specific recruitment to chromatin is linked to differential DNA methylation levels of its binding sites. Using neural differentiation as a model, we showed that induction of FOXA1 expression and its subsequent recruitment to enhancers is associated with DNA demethylation. Concomitantly, histone H3 lysine 4 methylation is induced at these enhancers. These epigenetic changes may both stabilize FOXA1 binding and allow for subsequent recruitment of transcriptional regulatory effectors. Interestingly, when cloned into reporter constructs, FOXA1-dependent enhancers were able to recapitulate their cell type specificity. However, their activities were inhibited by DNA methylation. Hence, these enhancers are intrinsic cell-type-specific regulatory regions of which activities have to be potentiated by FOXA1 through induction of an epigenetic switch that includes notably DNA demethylation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233399      PMCID: PMC3065703          DOI: 10.1101/gr.111534.110

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  69 in total

1.  FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

Authors:  Sunil Badve; Dmitry Turbin; Mangesh A Thorat; Akira Morimiya; Torsten O Nielsen; Charles M Perou; Sandi Dunn; David G Huntsman; Harikrishna Nakshatri
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

2.  Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector.

Authors:  Maja Klug; Michael Rehli
Journal:  Epigenetics       Date:  2006-08-28       Impact factor: 4.528

3.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

Review 4.  Crosstalk among Histone Modifications.

Authors:  Tamaki Suganuma; Jerry L Workman
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

5.  Chromatin dynamics during epigenetic reprogramming in the mouse germ line.

Authors:  Katia Ancelin; Tanja Waldmann; Petra Hajkova; Nicolas Lacoste; Ulrike C Lange; Francesca Cesari; Caroline Lee; Genevieve Almouzni; Robert Schneider; M Azim Surani
Journal:  Nature       Date:  2008-03-19       Impact factor: 49.962

6.  Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer.

Authors:  Jérôme Eeckhoute; Erika Krasnickas Keeton; Mathieu Lupien; Susan A Krum; Jason S Carroll; Myles Brown
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

7.  DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA.

Authors:  Steen K T Ooi; Chen Qiu; Emily Bernstein; Keqin Li; Da Jia; Zhe Yang; Hediye Erdjument-Bromage; Paul Tempst; Shau-Ping Lin; C David Allis; Xiaodong Cheng; Timothy H Bestor
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

8.  Cyclical DNA methylation of a transcriptionally active promoter.

Authors:  Raphaël Métivier; Rozenn Gallais; Christophe Tiffoche; Christine Le Péron; Renata Z Jurkowska; Richard P Carmouche; David Ibberson; Peter Barath; Florence Demay; George Reid; Vladimir Benes; Albert Jeltsch; Frank Gannon; Gilles Salbert
Journal:  Nature       Date:  2008-03-06       Impact factor: 49.962

9.  Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Authors:  M A Thorat; C Marchio; A Morimiya; K Savage; H Nakshatri; J S Reis-Filho; S Badve
Journal:  J Clin Pathol       Date:  2007-11-23       Impact factor: 3.411

10.  Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks.

Authors:  Daniel Zilberman; Devin Coleman-Derr; Tracy Ballinger; Steven Henikoff
Journal:  Nature       Date:  2008-09-24       Impact factor: 49.962

View more
  119 in total

Review 1.  FOXA1: master of steroid receptor function in cancer.

Authors:  Michael A Augello; Theresa E Hickey; Karen E Knudsen
Journal:  EMBO J       Date:  2011-09-20       Impact factor: 11.598

Review 2.  Enhancers: emerging roles in cell fate specification.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  EMBO Rep       Date:  2012-04-10       Impact factor: 8.807

3.  Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood.

Authors:  Gidon Toperoff; Dvir Aran; Jeremy D Kark; Michael Rosenberg; Tatyana Dubnikov; Batel Nissan; Julio Wainstein; Yechiel Friedlander; Ephrat Levy-Lahad; Benjamin Glaser; Asaf Hellman
Journal:  Hum Mol Genet       Date:  2011-10-12       Impact factor: 6.150

Review 4.  Impact of chromatin structure on PR signaling: transition from local to global analysis.

Authors:  Lars Grøntved; Gordon L Hager
Journal:  Mol Cell Endocrinol       Date:  2011-09-21       Impact factor: 4.102

5.  The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cells.

Authors:  Olivier Briand; Audrey Helleboid-Chapman; Maheul Ploton; Nathalie Hennuyer; Rodolphe Carpentier; François Pattou; Brigitte Vandewalle; Ericka Moerman; Valery Gmyr; Julie Kerr-Conte; Jérôme Eeckhoute; Bart Staels; Philippe Lefebvre
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 6.  Shaping Gene Expression by Landscaping Chromatin Architecture: Lessons from a Master.

Authors:  Vittorio Sartorelli; Pier Lorenzo Puri
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

Review 7.  Setting appropriate boundaries: fate, patterning and competence at the neural plate border.

Authors:  Andrew K Groves; Carole LaBonne
Journal:  Dev Biol       Date:  2013-12-07       Impact factor: 3.582

Review 8.  The molecular basis of craniofacial placode development.

Authors:  Sunita Singh; Andrew K Groves
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-03-07       Impact factor: 5.814

9.  Amplitude modulation of androgen signaling by c-MYC.

Authors:  Min Ni; Yiwen Chen; Teng Fei; Dan Li; Elgene Lim; X Shirley Liu; Myles Brown
Journal:  Genes Dev       Date:  2013-03-25       Impact factor: 11.361

10.  Genome-Wide Analysis of the FOXA1 Transcriptional Network Identifies Novel Protein-Coding and Long Noncoding RNA Targets in Colorectal Cancer Cells.

Authors:  Sarah B Lazar; Lorinc Pongor; Xiao Ling Li; Ioannis Grammatikakis; Bruna R Muys; Emily A Dangelmaier; Christophe E Redon; Sang-Min Jang; Robert L Walker; Wei Tang; Stefan Ambs; Curtis C Harris; Paul S Meltzer; Mirit I Aladjem; Ashish Lal
Journal:  Mol Cell Biol       Date:  2020-10-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.